The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with ...

Regular gabapentin use appeared to increase risk of dementia by 29% and mild cognitive impairment by 85%, researchers reported n the journal Regional Anesthesia & Pain Medicine. Photo by ...

Nerve pain affects millions of people worldwide, creating a burning, shooting, or electric sensation that can make daily activities nearly impossible. Unlike regular pain that responds well to common ...

Nerve or neuropathic pain has long been a tricky condition to treat effectively. However, a new study has comprehensively evaluated current drug and non-drug therapies to provide up-to-date guidelines ...

Chemotherapy has long forced patients to choose between fighting their cancer and living with nerve pain that can linger for years after treatment ends. Now a wave of basic science and early clinical ...

Editor’s Note (1/31/25): The U.S. Food and Drug Administration has approved the novel nonopioid medication suzetrigine for acute pain. That pain ranges from moderate to severe. The drug was tested in ...

A comprehensive review of clinical trials finds little convincing evidence that cannabis-based medicines provide real relief for chronic nerve pain.

Jim had completely lost feeling in his left foot when he came to Shift Health Center in Traverse City, Mich., searching for relief. Within three months, he regained more than half of the feeling in ...

Sleep quality is another area where users notice improvement. Rather than acting as a sleep aid, Nerve Calm supports ...

There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated review ...

There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated Cochrane review finds.